Cantero-Recasens et al. first described the involvement of TRPV1 in asthma pathophysiology and reported a protective effect of the TRPV1-Val-585 variant against the presence of wheezing or cough among asthmatics [85]. The gene discussed is TRPV1; the disease is asthma.